Clinical Trial Results:
a multicentre, open, uncontrolled phase IIIb study to evaluate the efficacy and safety of Etanercept 0,8 mg/kg body weight (bw) given once weekly to patients with polyarticular-course juvenile idiopathic arthritis (JIA) for 12 weeks
Summary
|
|
EudraCT number |
2007-000255-34 |
Trial protocol |
DE |
Global completion date |
10 Jun 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Oct 2020
|
First version publication date |
17 Oct 2020
|
Other versions |
|
Summary report(s) |
A mulitcentre, open, uncontrolled phase IIIb study to evaluate the efficacy and safety of etanercept 0,8 mg/kg body weight given once weekly to patients with polyarticular course JIA |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.